These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22986481)

  • 21. Are sleep studies helpful in children with Prader-Willi syndrome prior to commencement of growth hormone therapy?
    Vandeleur M; Davey MJ; Nixon GM
    J Paediatr Child Health; 2013 Mar; 49(3):238-41. PubMed ID: 23438058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GH treatment reduces total ghrelin in Prader-Willi syndrome (PWS) and may confound ghrelin studies in young PWS children.
    Hauffa BP; Petersenn S
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):155-6. PubMed ID: 19178506
    [No Abstract]   [Full Text] [Related]  

  • 23. Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial.
    Mogul HR; Lee PD; Whitman BY; Zipf WB; Frey M; Myers S; Cahan M; Pinyerd B; Southren AL
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1238-45. PubMed ID: 18211968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sudden death in Prader-Willi syndrome during growth hormone therapy.
    Sacco M; Di Giorgio G
    Horm Res; 2005; 63(1):29-32. PubMed ID: 15583479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome.
    Deal CL; Tony M; Höybye C; Allen DB; Tauber M; Christiansen JS;
    J Clin Endocrinol Metab; 2013 Jun; 98(6):E1072-87. PubMed ID: 23543664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatropin in Prader-Willi syndrome.
    Prescrire Int; 2004 Feb; 13(69):21. PubMed ID: 15055219
    [No Abstract]   [Full Text] [Related]  

  • 27. Dietary Energy Intake, Body Composition and Resting Energy Expenditure in Prepubertal Children with Prader-Willi Syndrome before and during Growth Hormone Treatment: A Randomized Controlled Trial.
    Bakker NE; Siemensma EP; Koopman C; Hokken-Koelega AC
    Horm Res Paediatr; 2015; 83(5):321-31. PubMed ID: 25764996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indications for growth hormone therapy in children.
    Kirk J
    Arch Dis Child; 2012 Jan; 97(1):63-8. PubMed ID: 21540481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study.
    Siemensma EP; Tummers-de Lind van Wijngaarden RF; Festen DA; Troeman ZC; van Alfen-van der Velden AA; Otten BJ; Rotteveel J; Odink RJ; Bindels-de Heus GC; van Leeuwen M; Haring DA; Oostdijk W; Bocca G; Mieke Houdijk EC; van Trotsenburg AS; Hoorweg-Nijman JJ; van Wieringen H; Vreuls RC; Jira PE; Schroor EJ; van Pinxteren-Nagler E; Willem Pilon J; Lunshof LB; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2307-14. PubMed ID: 22508707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone therapy in children with Prader-Willi syndrome.
    Franzese A; Romano A; Spagnuolo MI; Ruju F; Valerio G
    J Pediatr; 2006 Jun; 148(6):846; author reply 846-7. PubMed ID: 16769405
    [No Abstract]   [Full Text] [Related]  

  • 32. Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS.
    Eiholzer U
    Horm Res; 2005; 63(1):33-9. PubMed ID: 15604598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IGF-1 Levels, Complex Formation, and IGF Bioactivity in Growth Hormone-Treated Children With Prader-Willi Syndrome.
    Bakker NE; van Doorn J; Renes JS; Donker GH; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3041-9. PubMed ID: 26050733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
    Festen DA; de Lind van Wijngaarden R; van Eekelen M; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.
    de Lind van Wijngaarden RF; Siemensma EP; Festen DA; Otten BJ; van Mil EG; Rotteveel J; Odink RJ; Bindels-de Heus GC; van Leeuwen M; Haring DA; Bocca G; Houdijk EC; Hoorweg-Nijman JJ; Vreuls RC; Jira PE; van Trotsenburg AS; Bakker B; Schroor EJ; Pilon JW; Wit JM; Drop SL; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4205-15. PubMed ID: 19837938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An obese female with Prader-Willi syndrome and daytime sleepiness.
    Wagner MH; Berry RB
    J Clin Sleep Med; 2007 Oct; 3(6):645-7. PubMed ID: 17993048
    [No Abstract]   [Full Text] [Related]  

  • 37. Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee.
    Wilson TA; Rose SR; Cohen P; Rogol AD; Backeljauw P; Brown R; Hardin DS; Kemp SF; Lawson M; Radovick S; Rosenthal SM; Silverman L; Speiser P;
    J Pediatr; 2003 Oct; 143(4):415-21. PubMed ID: 14571209
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapy of growth disorders.
    Ali O; Wyatt D
    Curr Opin Endocrinol Diabetes Obes; 2011 Feb; 18(1):3-8. PubMed ID: 21150587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone therapy in the Prader-Willi syndrome.
    Paterson WF; Donaldson MD
    Arch Dis Child; 2003 Apr; 88(4):283-5. PubMed ID: 12651746
    [No Abstract]   [Full Text] [Related]  

  • 40. Growth hormone treatment improves vitality and behavioural issues in children with Prader-Willi syndrome.
    Böhm B; Ritzén EM; Lindgren AC
    Acta Paediatr; 2015 Jan; 104(1):59-67. PubMed ID: 25263744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.